Also trades as: BFRI (NASDAQ) · $vol 0M
BFRIW NASDAQ
Biofrontera Inc.
1W: -66.2%
1M: -72.5%
3M: -89.2%
YTD: -92.0%
1Y: -93.5%
3Y: -99.5%
$0.01
-0.00 (-30.61%)
Weekly Expected Move ±28.0%
$0
$0
$0
$0
$0
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Supply Chain
Supply Chain Overview
18 relationships17
As Filer
counterparties named
1
As Counterparty
mentioned by others
4
Rel. Types
2022-04-05
Earliest Filing
2025-11-07
Latest Filing
partner: 8
target: 5
acquirer: 2
investor: 2
Counterparties (Filed by BFRIW)
17 relationshipsCompanies named in BFRIW's SEC 8-K filings as business counterparties.
| Counterparty | Ticker | Relationship | Summary | Filing Date | SEC |
|---|---|---|---|---|---|
| Biofrontera Inc. | BFRIW | acquirer | Party to settlement agreement transferring shares to Maruho subsidiary | 2024-01-03 | View |
| Biofrontera Newderm LLC | BFRIW | partner | Successor entity to Biofrontera Inc. referenced in SPA | 2024-01-03 | View |
| Cutanea Life Sciences, Inc. | — | partner | Successor entity to Biofrontera Inc. referenced in SPA | 2024-01-03 | View |
| Maruho Co., Ltd. | — | target | Party to settlement agreement receiving shares from Biofrontera Inc. | 2024-01-03 | View |
| Maruho Deutschland GmbH | — | partner | Wholly owned subsidiary of Maruho receiving shares in settlement | 2024-01-03 | View |
| Biofrontera AG | BFRIW | target | German corporation whose shares are the subject of the transfer | 2024-01-03 | View |
| Biofrontera AG | BFRIW | investor | Significant stockholder and party to settlement agreement regarding board nominations and stockholder proposals. | 2023-04-17 | View |
| Deutsche Balaton Aktiengesellschaft | — | investor | Affiliate of Biofrontera AG mentioned in the context of beneficial ownership thresholds and director restrictions. | 2023-04-17 | View |
| Biofrontera Inc. | BFRIW | acquirer | Party to settlement allocation agreement | 2022-04-05 | View |
| Biofrontera Bioscience GmbH | BFRIW | partner | Party to settlement allocation agreement | 2022-04-05 | View |
| Biofrontera Pharma GmbH | BFRIW | partner | Party to settlement allocation agreement | 2022-04-05 | View |
| Biofrontera Development GmbH | BFRIW | partner | Party to settlement allocation agreement | 2022-04-05 | View |
| Biofrontera Neuroscience GmbH | BFRIW | partner | Party to settlement allocation agreement | 2022-04-05 | View |
| Biofrontera AG | BFRIW | partner | Party to settlement allocation agreement | 2022-04-05 | View |
| DUSA Pharmaceuticals, Inc. | — | target | Counterparty in underlying settlement claims | 2022-04-05 | View |
| Sun Pharmaceutical Industries, Inc. | — | target | Counterparty in underlying settlement claims | 2022-04-05 | View |
| Sun Pharmaceutical Industries Ltd. | — | target | Counterparty in underlying settlement claims | 2022-04-05 | View |
Mentioned As Counterparty
1 mentionsOther companies that named BFRIW in their SEC 8-K filings.
Recent 8-K Filings (20)
| Filing Date | Description | Type | SEC |
|---|---|---|---|
| 2026-09-14 | Other Events; Exhibits | View | |
| 2026-08-13 | Earnings Release; Exhibits | View | |
| 2026-06-17 | Shareholder Vote | View | |
| 2026-05-14 | Earnings Release; Exhibits | View | |
| 2026-03-09 | Regulation FD Disclosure; Financial Statements and Exhibits | View | |
| 2026-02-26 | Other Events; Financial Statements and Exhibits | View | |
| 2026-02-09 | Regulation FD Disclosure; Financial Statements and Exhibits | View | |
| 2026-01-13 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2026-01-07 | Notice of Delisting or Transfer | View | |
| 2025-11-13 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2025-11-10 | Other Events | View | |
| 2025-11-07 | Entry into Material Definitive Agreement; Completion of Acquisition or Disposition of Assets; Regula | Agreement Acquisition | View |
| 2025-10-24 | Entry into Material Definitive Agreement; Completion of Acquisition or Disposition of Assets; Unregi | Agreement Acquisition | View |
| 2025-10-23 | Regulation FD Disclosure; Financial Statements and Exhibits | View | |
| 2025-09-19 | Submission of Matters to a Vote of Security Holders | View | |
| 2025-08-13 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2025-08-11 | Departure/Election of Directors; Appointment of Officers; Regulation FD Disclosure; Financial Statem | View | |
| 2025-07-16 | Financial Statements and Exhibits | View | |
| 2025-07-01 | Entry into Material Definitive Agreement; Unregistered Sales of Equity Securities; Material Modifica | Agreement | View |
| 2025-06-30 | Regulation FD Disclosure; Financial Statements and Exhibits | View |
Data extracted from SEC EDGAR 8-K filings using NLP. Relationships are as disclosed in filing text.
Covers 2021–2026. View on SEC EDGAR